American Journal of Kidney Diseases
Volume 51, Issue 5 , Pages 777-788 , May 2008

Improving Care of Patients With Diabetes and CKD: A Pilot Study for a Cluster-Randomized Trial

Received 6 March 2007 ,Accepted 6 December 2007.

References 

  1. US Renal Data System. Chronic Kidney Disease. http://www.usrds.orgAccessed February 27, 2007
  2. ERA-EDTA Registry. ERA-EDTA Registry 2004 Annual Report. Amsterdam, The Netherlands, Academic Medical Center, July 2006. http://www.era-edta-reg.orgAccessed February 27, 2007
  3. Sociedad Latinoamericana de Hipertensión y Nefrología: Registro Latinoamericano de Diálisis y Transplante. Informe del ãno 2002. http://www.slanh.orgAccessed February 27, 2007
  4. Breien Alcaraz H, García Bejarano H, García García G, et al. Epidemiología de la Insuficiencia Renal Crónica en Jalisco. Bol Colegio Jalisciense Nefrol AC. 2001;5:6–7
  5. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1–S266
  6. Amato D, Alvarez-Aguilar C, Castañeda-Limones R, et al. Prevalence of chronic kidney disease in an urban Mexican population. Kidney Int Suppl. 2005;97:S11–S17
  7. Cueto-Manzano AM, Cortes-Sanabria L, Martínez-Ramírez HR, et al. Detection of early nephropathy in Mexican patients with type 2 diabetes mellitus. Kidney Int Suppl. 2005;97:S40–S45
  8. Jones CA, Francis ME, Eberhardt MS, et al. Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2002;39:445–459
  9. Obrador GT, Pereira BJ. Early referral to the nephrologist and timely initiation of renal replacement therapy: A paradigm shift in the management of patients with chronic renal failure. Am J Kidney Dis. 1998;31:398–417
  10. Levin A. Identification of patients and risk factors in chronic kidney disease—Evaluating risk factors and therapeutic strategies. Nephrol Dial Transplant. 2001;16(suppl 7):S57–S60
  11. Hebert LA, Wilmer WA, Falkenhain ME, Ladson-Wofford SE, Nahman NE, Rovin BH. Renoprotection: One or many therapies?. Kidney Int. 2001;59:1211–1226
  12. Martínez-Ramírez RH, Jalomo-Martínez B, Cortes-Sanabria L, et al. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: A comparative prospective cohort study between primary health care doctors and nephrologist. Am J Kidney Dis. 2006;47:78–87
  13. Consejo Mexicano de Nefrología: Nefrólogos certificados. http://www.consejomexicanodenefrologia.com.mxAccessed February 27, 2007
  14. Velásquez-Monroy O, Rosas Peralta M, Lara Esqueda A, et al. Grupo ENSA 2000 Prevalencia e interrelación de enfermedades crónicas no transmisibles y factores de riesgo cardiovascular en México: Resultados finales de la encuesta nacional de salud (ENSA) 2000. Arch Cardiol Mex. 2003;73:62–77
  15. Snyder S, Pendergraph B. Detection and evaluation of chronic kidney disease. Am Fam Physician. 2005;72:1723–1732
  16. Levinsky NG. Specialist evaluation in chronic kidney disease: Too much, too late. Ann Intern Med. 2002;137:542–543
  17. Cox M, Irby DM. Assessment in medical education. N Engl J Med. 2007;356:387–396
  18. Brown N, Doshi M. Assessing professional and clinical competence: The way forward. Adv Psychiatr Treat. 2006;12:81–91
  19. Cabrera PC, Chávez SA, González RH, Cortés SL. Valoración global de la aptitud clínica de médicos familiares en el manejo de la diabetes mellitus con nefropatía inicial. Rev Invest Clin. 2005;57:685–690
  20. Viniegra Velásquez L. La crítica: Aptitud olvidada por la educación, Primera Edición. México: Instituto Mexicano del Seguro Social, Mexico City; 2000;
  21. Bowen JL. Educational strategies to promote clinical diagnostic reasoning. N Engl J Med. 2006;355:2217–2225
  22. Cueto-Manzano AM, Rojas-Campos E. Status of renal replacement therapy and peritoneal dialysis in Mexico. Perit Dial Int. 2007;27:142–148
  23. American Diabetes Association. Standards of medical care in diabetes 2007. Diabetes Care. 2007;30(suppl 1):S4–S41
  24. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–254
  25. Pérez-Padilla PR, Viniegra VL. Método para calcular la distribución de las calificaciones esperadas por azar en un examen del tipo falso, verdadero y no sé. Rev Invest Clin. 1989;41:375–379
  26. Reed JF. Adjusted chi-square statistics: Application to clustered binary data in primary care. Ann Fam Med. 2004;2:201–203
  27. Zimmerman DL, Selick A, Singh R, Mendelssohn DC. Attitudes of Canadian nephrologists, family physicians and patients with kidney failure toward primary care delivery for chronic dialysis patients. Nephrol Dial Transplant. 2003;18:305–309
  28. Kuyvenhoven MM, Pieters HM, Jacobs HM, Touw-Otten FWMM, Spreeuwenberg C. The association between peer consultations and three aspects of clinical competence. Fam Pract. 1990;3:163–167
  29. Jaber BL, Madias NE. Progression of chronic kidney disease: Can it be prevented or arrested?. Am J Med. 2005;118:1323–1330
  30. Levey AS, Bosch JP, Breyer Lewis J, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med. 1999;130:461–470
  31. Withcomb M. More on competency-based education. Acad Med. 2004;79:493–494
  32. Peterson JC, Adler S, Burkart JM, et al. Blood pressure control, proteinuria and the progression of renal disease (The Modification of Diet in Renal Disease Study). Ann Intern Med. 1995;123:754–762
  33. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:861–869
  34. Barnett AH, Stephen CB, Bouter P, et al. Angiotensin-receptor blockade versus converting enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med. 2004;351:1952–1961
  35. Pugliese F, Cinotti GA. Nonsteroidal anti-inflammatory drugs (NSAIDs) and the kidney. Nephrol Dial Transplant. 1997;12:386–388
  36. Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: A meta-analysis. Kidney Int. 2001;59:260-169
  37. MaClellan WM. Epidemiology and risk factors for chronic kidney disease. Med Clin North Am. 2005;89:419–445
  38. Chuahirun T, Wesson DE. Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition. Am J Kidney Dis. 2002;39:376–382
  39. Killip S, Mahfoud Z, Pearce K. What is an intracluster correlation coefficient? (Crucial concepts for primary care researchers). Ann Fam Med. 2004;2:204–208

 A list of author affiliations appears at the end of this article.

PII: S0272-6386(08)00158-3

doi: 10.1053/j.ajkd.2007.12.039

American Journal of Kidney Diseases
Volume 51, Issue 5 , Pages 777-788 , May 2008

Article Tools

* Image Usage & Resolution